MX2018016033A - Metodo para purificar eritropoyetina pegilada. - Google Patents
Metodo para purificar eritropoyetina pegilada.Info
- Publication number
- MX2018016033A MX2018016033A MX2018016033A MX2018016033A MX2018016033A MX 2018016033 A MX2018016033 A MX 2018016033A MX 2018016033 A MX2018016033 A MX 2018016033A MX 2018016033 A MX2018016033 A MX 2018016033A MX 2018016033 A MX2018016033 A MX 2018016033A
- Authority
- MX
- Mexico
- Prior art keywords
- erythropoietin
- residue
- ethylene glycol
- cation exchange
- exchange chromatography
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 108010048732 pegylated erythropoietin Proteins 0.000 title 1
- 102000003951 Erythropoietin Human genes 0.000 abstract 2
- 108090000394 Erythropoietin Proteins 0.000 abstract 2
- 238000005277 cation exchange chromatography Methods 0.000 abstract 2
- 229940105423 erythropoietin Drugs 0.000 abstract 2
- 229920001223 polyethylene glycol Polymers 0.000 abstract 2
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 abstract 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical group OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 abstract 1
- 239000007795 chemical reaction product Substances 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 238000010517 secondary reaction Methods 0.000 abstract 1
- 239000007858 starting material Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
- B01D15/361—Ion-exchange
- B01D15/362—Cation-exchange
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/505—Erythropoietin [EPO]
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
En la presente se reporta un método para la purificación de una proteína que comprende eritropoyetina y un residuo único de poli(etilenglicol) a partir de productos secundarios de reacción o material inicial que no ha reaccionado, por un método de cromatografía de intercambio catiónico. Se ha encontrado que al usar un material de cromatografía de intercambio catiónico ToyopearlMR SP-650 y usando una segunda etapa de lavado con un valor de pH incrementado en comparación con la primera etapa de lavado se puede obtener una proteína de fusión de eritropoyetina y un residuo único de poli(etilenglicol) en una etapa única con alta pureza y rendimiento, y adecuado para aplicaciones a gran escala.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16179755 | 2016-07-15 | ||
| PCT/EP2017/067790 WO2018011381A1 (en) | 2016-07-15 | 2017-07-13 | Method for purifying pegylated erythropoietin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2018016033A true MX2018016033A (es) | 2019-05-13 |
| MX391087B MX391087B (es) | 2025-03-21 |
Family
ID=56497564
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018016033A MX391087B (es) | 2016-07-15 | 2017-07-13 | Método para purificar eritropoyetina pegilada. |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US20190300567A1 (es) |
| EP (1) | EP3484911B1 (es) |
| JP (2) | JP7177035B2 (es) |
| KR (2) | KR102820834B1 (es) |
| CN (1) | CN109415427A (es) |
| AU (1) | AU2017295037B2 (es) |
| BR (1) | BR112018076390A2 (es) |
| ES (1) | ES2841648T3 (es) |
| HR (1) | HRP20202077T1 (es) |
| IL (1) | IL264153B (es) |
| MX (1) | MX391087B (es) |
| PL (1) | PL3484911T3 (es) |
| SG (1) | SG11201811553UA (es) |
| SI (1) | SI3484911T1 (es) |
| WO (1) | WO2018011381A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102820834B1 (ko) | 2016-07-15 | 2025-06-13 | 에프. 호프만-라 로슈 아게 | Ｐｅｇ화 에리트로포이에틴을 정제하기 위한 방법 |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5118796A (en) | 1987-12-09 | 1992-06-02 | Centocor, Incorporated | Efficient large-scale purification of immunoglobulins and derivatives |
| FR2646438B1 (fr) | 1989-03-20 | 2007-11-02 | Pasteur Institut | Procede de remplacement specifique d'une copie d'un gene present dans le genome receveur par l'integration d'un gene different de celui ou se fait l'integration |
| WO1991006666A1 (en) | 1989-11-06 | 1991-05-16 | Cell Genesys, Inc. | Production of proteins using homologous recombination |
| EP0779362B2 (en) | 1989-12-22 | 2012-06-13 | Laboratoires Serono SA | DNA constructs for endogenous gene activation and expression modification |
| JPH04218000A (ja) | 1990-02-13 | 1992-08-07 | Kirin Amgen Inc | 修飾ポリペプチド |
| JP3051145B2 (ja) | 1990-08-28 | 2000-06-12 | 住友製薬株式会社 | 新規なポリエチレングリコール誘導体修飾ペプチド |
| DE4118912C1 (es) | 1991-06-08 | 1992-07-02 | Biotest Pharma Gmbh, 6072 Dreieich, De | |
| US5733761A (en) | 1991-11-05 | 1998-03-31 | Transkaryotic Therapies, Inc. | Protein production and protein delivery |
| US5641670A (en) | 1991-11-05 | 1997-06-24 | Transkaryotic Therapies, Inc. | Protein production and protein delivery |
| PT101031B (pt) | 1991-11-05 | 2002-07-31 | Transkaryotic Therapies Inc | Processo para o fornecimento de proteinas por terapia genetica |
| FR2686899B1 (fr) | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
| ATE225801T1 (de) | 1992-07-13 | 2002-10-15 | Bionebraska Inc | Verfahren zur modifizierung rekombinanter polypeptide |
| TW402639B (en) | 1992-12-03 | 2000-08-21 | Transkaryotic Therapies Inc | Protein production and protein delivery |
| JPH08176133A (ja) * | 1994-12-26 | 1996-07-09 | Takeda Chem Ind Ltd | Ｌ−アスコルビン酸の精製法 |
| US5932462A (en) | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
| CN1260249C (zh) | 1998-05-06 | 2006-06-21 | 基因技术股份有限公司 | 用离子交换层析纯化蛋白质 |
| DE60004172T2 (de) | 1999-01-29 | 2004-04-22 | F. Hoffmann-La Roche Ag | Gcsf konjugate |
| CZ299516B6 (cs) | 1999-07-02 | 2008-08-20 | F. Hoffmann-La Roche Ag | Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem |
| JO2291B1 (en) * | 1999-07-02 | 2005-09-12 | اف . هوفمان لاروش ايه جي | Erythropoietin derivatives |
| ATE336514T1 (de) | 2000-02-11 | 2006-09-15 | Merck Patent Gmbh | Steigerung der zirkulierenden halbwertzeit von auf antikörpern basierenden fusionsproteinen |
| US20050100991A1 (en) | 2001-04-12 | 2005-05-12 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| DK1543038T4 (da) | 2002-09-11 | 2020-11-09 | Genentech Inc | Proteinoprensning |
| US7610156B2 (en) | 2003-03-31 | 2009-10-27 | Xencor, Inc. | Methods for rational pegylation of proteins |
| US20050008649A1 (en) | 2003-06-02 | 2005-01-13 | University Of Miami | Chimeric molecules and methods of use |
| CL2008002053A1 (es) * | 2007-07-17 | 2009-05-22 | Hoffmann La Roche | Metodo para la purificacion de una eritropoyetina monopeguilada (epompeg) que consiste en proporcionar una solucion que contiene eritropoyetina mono, poli y no peguilada y hacerla pasar por dos pasos de cromatografia de intercambio cationico y metodo para producir epo mpeg que incluye metodo de purificacion. |
| HUE027668T2 (en) * | 2007-10-30 | 2016-11-28 | Genentech Inc | Antibody purification by cation exchange chromatography |
| DE102008002209A1 (de) * | 2008-06-04 | 2009-12-10 | Evonik Degussa Gmbh | Verfahren zur Aufreinigung von Erythropoietin |
| JP5632376B2 (ja) * | 2008-09-23 | 2014-11-26 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | エリスロポエチンの精製 |
| AU2009324204B2 (en) * | 2008-12-02 | 2014-10-16 | Novo Nordisk Health Care Ag | Polypeptide purification |
| CN102711978B (zh) * | 2010-01-08 | 2015-11-25 | 塔斯马尼亚大学 | 多孔聚合物整料、其制备方法及其用途 |
| SI2616101T1 (sl) * | 2010-09-14 | 2014-10-30 | F. Hoffmann-La Roche Ag | Postopek za čiščenje pegiliranega eritropoetina |
| KR102820834B1 (ko) * | 2016-07-15 | 2025-06-13 | 에프. 호프만-라 로슈 아게 | Ｐｅｇ화 에리트로포이에틴을 정제하기 위한 방법 |
-
2017
- 2017-07-13 KR KR1020227040439A patent/KR102820834B1/ko active Active
- 2017-07-13 KR KR1020197001213A patent/KR102470282B1/ko active Active
- 2017-07-13 JP JP2019501473A patent/JP7177035B2/ja active Active
- 2017-07-13 MX MX2018016033A patent/MX391087B/es unknown
- 2017-07-13 SI SI201730577T patent/SI3484911T1/sl unknown
- 2017-07-13 PL PL17745145T patent/PL3484911T3/pl unknown
- 2017-07-13 EP EP17745145.7A patent/EP3484911B1/en active Active
- 2017-07-13 ES ES17745145T patent/ES2841648T3/es active Active
- 2017-07-13 BR BR112018076390A patent/BR112018076390A2/pt active Search and Examination
- 2017-07-13 WO PCT/EP2017/067790 patent/WO2018011381A1/en not_active Ceased
- 2017-07-13 AU AU2017295037A patent/AU2017295037B2/en active Active
- 2017-07-13 CN CN201780042430.1A patent/CN109415427A/zh active Pending
- 2017-07-13 HR HRP20202077TT patent/HRP20202077T1/hr unknown
- 2017-07-13 SG SG11201811553UA patent/SG11201811553UA/en unknown
-
2019
- 2019-01-09 IL IL264153A patent/IL264153B/en unknown
- 2019-01-10 US US16/245,081 patent/US20190300567A1/en not_active Abandoned
-
2021
- 2021-01-11 US US17/145,653 patent/US11993630B2/en active Active
-
2022
- 2022-11-10 JP JP2022180041A patent/JP7530413B2/ja active Active
-
2024
- 2024-04-24 US US18/645,245 patent/US20250136639A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ES2841648T3 (es) | 2021-07-08 |
| US20190300567A1 (en) | 2019-10-03 |
| IL264153B (en) | 2021-09-30 |
| JP7177035B2 (ja) | 2022-11-22 |
| CA3027143A1 (en) | 2018-01-18 |
| JP2023015257A (ja) | 2023-01-31 |
| IL264153A (en) | 2019-02-28 |
| KR102820834B1 (ko) | 2025-06-13 |
| AU2017295037A1 (en) | 2019-01-24 |
| SI3484911T1 (sl) | 2021-02-26 |
| AU2017295037B2 (en) | 2021-07-22 |
| US20250136639A1 (en) | 2025-05-01 |
| MX391087B (es) | 2025-03-21 |
| HRP20202077T1 (hr) | 2021-02-19 |
| KR20220158870A (ko) | 2022-12-01 |
| CN109415427A (zh) | 2019-03-01 |
| KR20190026759A (ko) | 2019-03-13 |
| EP3484911A1 (en) | 2019-05-22 |
| PL3484911T3 (pl) | 2021-03-08 |
| WO2018011381A1 (en) | 2018-01-18 |
| EP3484911B1 (en) | 2020-11-04 |
| US20210155655A1 (en) | 2021-05-27 |
| JP2019524726A (ja) | 2019-09-05 |
| BR112018076390A2 (pt) | 2019-03-26 |
| KR102470282B1 (ko) | 2022-11-24 |
| US11993630B2 (en) | 2024-05-28 |
| SG11201811553UA (en) | 2019-01-30 |
| JP7530413B2 (ja) | 2024-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2017011957A2 (es) | Variantes de alfa-amilasa y polinucleótidos que codifican las mismas | |
| WO2012138927A3 (en) | Method for the generation of compact tale-nucleases and uses thereof | |
| MX2019008780A (es) | Composiciones detergentes. | |
| CU20170039A7 (es) | Método de purificación del anticuerpo humanizado 9e4 | |
| IT201900025039A1 (it) | Processo per purificare il bis(2-idrossietil)tereftalato. | |
| MX2017016109A (es) | Microorganismo recombinante para la produccion mejorada de productos quimicos finos. | |
| AR076027A1 (es) | Metodos e intermediarios para la preparacion de agentes farmaceuticos | |
| ATE522485T1 (de) | Oligomerisierung von isobutenhaltigen einsatzmaterialien | |
| MX2017011121A (es) | Uso de lavados alcalinos durante la cromatografia para remover impurezas. | |
| AR091218A1 (es) | Agente terapeutico o agente profilactico para los trastornos cognitivos | |
| BR112018001255A2 (pt) | composto direcionado à il-23a e fator de ativação de células b (baff) e seus usos | |
| MX2019000805A (es) | Variantes de serinproteasa y polinucleotidos que las codifican. | |
| AR074637A1 (es) | Formas de sal de adicion acida de r-(+)-n-propargil-1-aminoindano (es decir , base de rasagilina), un compuesto de formula (1), procesos para prepararlos y aislarlos y usos de los mismos | |
| BR112022006052A2 (pt) | Processo para a preparação de protioconazol | |
| BR112017009223A2 (pt) | módulo de biorreator eletroquímico melhorado e uso do mesmo | |
| ATE468311T1 (de) | Diisobutylenverfahren | |
| BR112018004861A8 (pt) | Processo para purificação de hidrolisado de biomassa | |
| AR095727A1 (es) | Preparación de intermediarios de pirimidina | |
| BR112017019631A2 (pt) | ?microrganismo recombinante, composição, métodos para produzir um microrganismo recombinante, para produzir piruvato, succinato, aspartato, malato, lactato, valina, leucina e/ou alanina, e para cultivar ou desenvolver um microrganismo geneticamente modificado, uso de um microrganismo recombinante, processo para produção fermentativa de piruvato, succinato, aspartato, malato, lactato, valina, leucina e/ou alanina, construção de expressão recombinante, e, vetor recombinante? | |
| BR112013022304A2 (pt) | processo para a recuperação contínua de ácido (met) acrílico e aparelho para o processo | |
| MX2018016033A (es) | Metodo para purificar eritropoyetina pegilada. | |
| AR100131A1 (es) | Proceso de purificación de gonadotropina | |
| MY202451A (en) | Catalysts for the synthesis of alkanesulfonic acids | |
| GT201100241A (es) | Proceso para preparar compuestos antivirales | |
| CO2017006157A2 (es) | Método de manufactura de proteína |